Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: Role of cytokines

Blood

Volumn 89, Issue 6, 1997, Pages 1931-1938

  Lindner, Heidrun ^a   Holler, Ernst ^a   Ertl, Birgit ^a   Multhoff, Gabriele ^a   Schreglmann, Manuela ^a   Klauke, Ines ^a   Schultz Hector, Susanne ^a   Eissner, Günther ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ETIOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; TISSUE REPAIR; VASCULAR ENDOTHELIUM;

EID: 0030946393     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.1931     Document Type: Article

References (36)

1. Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, Seeber C, Jehn U, Gerhartz HH, Brehm G, Wilmanns W: Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 73:2018, 1989
2. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Miachaeli J, Vlodavsky I, Fuks Z: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 54:2591, 1994
3. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW, Holler E: Critical involvement of transmembrane tumor necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86:4184, 1995
4. Reinhold HS, Fajardo LF, Hopewell JW: The vascular system. Adv Radiat Biol 14:177, 1990
5. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A: Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 54:2582, 1994
6. Xun CQ, Brown BA, Jennings CD, Henslee-Downey PJ, Thompson JS: Acute graft-versus-host-like diseases induced by transplantation of human activated natural killer cells into SCID mice. Transplantation 56:409, 1993
7. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ, Hartz AJ, Rimm AA: Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 104:168, 1986
8. Antin JH, Ferrara JLM: Cytokine dysregulation and acute graftversus-host disease. Blood 80:2964, 1992
9. Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixner B, Riedner C, Ledderose G, Brehm G, Mittermüller J, Wilmanns W. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 75:1011, 1990
10. Holler E, Kolb HJ, Mittermueller J, Kaul M, Ledderose G, Duell T, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, Kempeni J, Wilmanns W: Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNFα) release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF α (MAK195F). Blood 86:890, 1995
11. Jaffe EA, Nachman NL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
12. Möller A, Emling F, Blohm D, Schlick E, Schollmeier K: Monoclonal antibodies to human tumor necrosis factor alpha: In vitro and in vivo application. Cytokine 2:162, 1990
13. Lee A, Whyte MK, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators: J Leukoc Biol 54:283, 1993
14. Wright SC, Kumar P, Tam AW, Shen N, Varma M, Larrick JW: Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344, 1992
15. Cotter TG, Lennon SV, Glynn JM, Green DR: Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 52:997, 1992
16. Jung T, Schauer U, Heusser C, Neumann C, Rieger C, Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197, 1993
17. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957, 1993
18. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE: Endotoxemia in human septic shock. Chest 99:169, 1991
19. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15:7, 1994
20. Frater-Schroder M, Muller G, Birchmeier W, Bohlen P: Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137:295, 1986
21. Heimark RL, Twardzik DR, Schwartz SM: Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233:1078, 1986
22. Ziegler-Heitbrock HWL, Thiel E, Fütterer A, Herzog V, Wirtz A, Riethmüller G: Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41:455, 1988
23. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M: A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251, 1990
24. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K Scheurich P: The transmembrane form of tumor necrosis factor is the prime ligand of the 8OkDa tumor necrosis factor receptor. Cell 83:793, 1995
25. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor a during graft-versus-host disease. J Exp Med 175:405, 1992
26. Ferran C, Dautry F, Merite S, Sheeman K, Schreiber R, Gau G, Bach JF, Chatenoud L: Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest 93:2189, 1994
27. Van-Vlasselaer P, Borremans B, van-Gorp U, Dasch JR, DeWaal-Malefyt R: Interleukin 10 inhibits transforming growth factor-beta (TGF-β) synthesis for osteogenic commitment of mouse bone marrow cells. J Cell Biol 124:569, 1994
28. Lauk S, Trott KR: Endothelial cell proliferation in the rat heart following local heart irradiation, Int J Radiat Biol 57:1017, 1990
29. Jürgensmeier JM, Schmitt CP, Viesel E, Höfler P, Bauer G: Transforming growth factor β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 54:393, 1994
30. Moore KW, O'Garra AO, de Waal Malefyt R, Vieira P, Mosmann TR: interleukin-10. Annu Rev Immunol 11:165, 1993
31. Taga K, Cherney B, Tosato G: IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 5:1599, 1993
32. Gerard C, Bruyns C, Marchant A, Abrampvicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547, 1993
33. Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205, 1993
34. Vora M, Yssel H, de Vries JE, Karasek MA: Antigen presentation by human dermal microvascular endothelial cells. J Immunol 152:5734, 1994
35. Eissner G, Lindner H, Behrends U, Kolch W, Hieke A, Klauke I, Bornkamm GW, Holler E: Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: Protective role of IL-10. Transplantation 62:819, 1996
36. de Waal Malefyt R, Abrahms J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991